MULTIVIR Trademark

Trademark Overview


On Tuesday, January 2, 2018, a trademark application was filed for MULTIVIR with the United States Patent and Trademark Office. The USPTO has given the MULTIVIR trademark a serial number of 87741103. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 27, 2020. This trademark is owned by MultiVir Inc.. The MULTIVIR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Gene therapy based pharmaceutical drug research and development in the field of biotech therapeutics; development of gene therapy-based pharmaceutical drugs and therapeutic compounds; development of drugs for the pharmaceutical and biotech industries for the treatment of a wide variety of diseases and other conditions, namely, cancer and other hyperproliferative disorders; Scientific and technological research services in the field of biomarker profiles predicting gene therapy efficacy; providing "in vitro" and "in vivo" preclinical and clinical testing of gene therapy products for scientific, research, healthcare, product development, consulting, and educational purposes
multivir

General Information


Serial Number87741103
Word MarkMULTIVIR
Filing DateTuesday, January 2, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 27, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesGene therapy based pharmaceutical drug research and development in the field of biotech therapeutics; development of gene therapy-based pharmaceutical drugs and therapeutic compounds; development of drugs for the pharmaceutical and biotech industries for the treatment of a wide variety of diseases and other conditions, namely, cancer and other hyperproliferative disorders; Scientific and technological research services in the field of biomarker profiles predicting gene therapy efficacy; providing "in vitro" and "in vivo" preclinical and clinical testing of gene therapy products for scientific, research, healthcare, product development, consulting, and educational purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 17, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMultiVir Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77010

Trademark Events


Event DateEvent Description
Monday, January 27, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, January 27, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, July 16, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 16, 2019NON-FINAL ACTION E-MAILED
Tuesday, July 16, 2019NON-FINAL ACTION WRITTEN
Tuesday, June 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 17, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 17, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, December 17, 2018PRIORITY ACTION E-MAILED
Monday, December 17, 2018PRIORITY ACTION WRITTEN
Tuesday, November 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 29, 2018ASSIGNED TO LIE
Wednesday, October 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 18, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 18, 2018NON-FINAL ACTION E-MAILED
Wednesday, April 18, 2018NON-FINAL ACTION WRITTEN
Wednesday, April 11, 2018ASSIGNED TO EXAMINER
Wednesday, January 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 5, 2018NEW APPLICATION ENTERED IN TRAM